АЛВИ Джон Д. (US),БЕРСЕТ Кэрол Линн (US),ШАДЕ Дебора (US),МОРРИС Кристин (US)
申请号：
RU2013124962/13
公开号：
RU2013124962A
申请日:
2011.11.22
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. A nutritional supplement for enteral administration to premature infants, comprising: a lipid component, wherein the lipid component comprises at least about 0.64% arachidonic acid and at least about 0.32% docosahexaenoic acid, with arachidonic acid and docosahexaenoic acid are present in emulsified form. The nutritional supplement according to claim 1, wherein the lipid component comprises at least about 1% docosahexaenoic acid. The nutritional supplement according to claim 1, wherein the lipid component comprises at least about 2% docosahexaenoic acid. The nutritional supplement according to claim 1, characterized in that the nutritional supplement is formulated to deliver at least about 50 mg / kg / day of docosahexaenoic acid. The nutritional supplement according to claim 1, characterized in that the nutritional supplement is formulated to deliver at least about 60 mg / kg / day of docosahexaenoic acid. The nutritional supplement of claim 1, further comprising a protein component. The nutritional supplement of claim 1, further comprising a carbohydrate component. The nutritional supplement of claim 1, further comprising a vitamin and mineral component. The nutritional supplement of claim 1, further comprising at least one probiotic. The nutritional supplement of claim 1, further comprising at least one prebiotic. An enrichment component for oral administration to preterm infants, comprising: a lipid component, wherein the lipid component comprises at least about 0.64% arachidonic acid and at least about 0.32% docosahexaenoic acid, with arachidonic acid and docosahexaenoic k��1. Питательная добавка для энтерального введения недоношенным младенцам, содержащая:липидный компонент, при этом липидный компонент включает, по меньшей мере, около 0,64% арахидоновой кислоты и, по меньшей мере, около 0,32% докозагексаеновой кислоты, при этом арахидоновая кислота и докозагексаеновая кислота присутствуют в эмульгированной форме.2. Питательная добавка по п.1, отличающаяся т
